BioSpace News Archive

Sea turtles suffering from toxic red tide exposure could benefit from a therapy used to treat human drug overdoses.

Michele F. Loscocco is new leader of prominent Mid-Atlantic medical physics consulting company.

Study Published in Scientific Reports Demonstrates Prevention of Inflammation in a Cardiovascular Disease Model

Luminaries from industry, healthcare and academia are converging at the Leadership in the Age of Personalization® Executive Summit, on October 9, 2019 in Huntington Beach, California, presented by GLLG.

Bringing back the power of the close doctor-patient relationship and improving access to healthcare is the focus of a new collaborative partnership between the New Jersey Health Insurance Fund (hi) and R-Health, a leader in Direct Primary Care based in Elkins Park, Pa.

The global orphan drugs market analysis and forecast 2019-2023 has been added to Technavio’s catalog.

Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc., released its fourth annual Medicaid Pharmacy Trend ReportTM, the industry’s leading report that is developed through in-depth data analysis and supported by Magellan’s broad national experience managing fee-for-service Medicaid pharmacy programs.

ImmunoGen, Inc. announced that full data and additional exploratory analyses from the Phase 3 FORWARD I study evaluating mirvetuximab soravtansine compared to chemotherapy in women with folate receptor alpha (FRα)-positive, platinum-resistant ovarian cancer will be presented during an oral presentation at the European Society for Medical Oncology (ESMO) Congress to be held from September 27 to October 1, 2019 in Barcelona, Spain.

Solasia Pharma K.K. announced that patient registration reached the target number of cases for the darinaparsin Phase 2 study.

Zymeworks Inc. announced that Lota Zoth has been appointed as its Chair of the Board of Directors.